{"chunk_type":"transcript_chunk","text":"# Diabetes Classification + Screening + Complication Monitoring\n## Subtype differentiation\n- MODY는 젊고 마른 환자에서도 가능하며 autoantibody negative + preserved C-peptide + strong autosomal dominant family history가 단서.\n- type 1/2 가정 대신 biochemical evidence 기반 분류가 Step 2 핵심.\n\n## Screening and diagnosis\n- 성인 screening은 연령/체중/위험군(이식, HIV, CF 등) 맥락으로 확장 적용.\n- 진단은 A1c, fasting glucose, random glucose(증상 동반), OGTT 기준을 상황별로 사용.\n\n## Health maintenance\n- 합병증 screening: kidney(UACR), retina(유형별 시점 차이), neuropathy(foot exam), ASCVD risk 동시 관리.\n- 목표 A1c는 연령/동반질환/저혈당 위험에 따라 개인화.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-61","focus_area":"Diabetes Classification and Screening","tags":["usmle-step2","endocrinology","diabetes","diagnosis","screening"]}
{"chunk_type":"transcript_chunk","text":"# Gastroparesis + DKA Entry Logic\n## Gastroparesis clue\n- 당뇨 환자에서 식후 오심/구토 + 식후 저혈당 패턴은 delayed gastric emptying과 insulin timing mismatch를 시사.\n\n## DKA clinical signal\n- polyuria/polydipsia, abdominal pain, Kussmaul respiration, ketosis/anion-gap acidosis를 하나의 syndrome으로 묶어 해석.\n- stress hyperglycemia는 중환자 상황에서 adaptive response일 수 있어 context-based 해석 필요.\n\n## Transition\n- 이후 관리는 DKA/HHS 분기와 응급 프로토콜 우선순위(수액-전해질-인슐린)로 이어진다.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-81","focus_area":"Gastroparesis and DKA Entry","tags":["usmle-step2","endocrinology","diabetes","gastroparesis","dka"]}
{"chunk_type":"transcript_chunk","text":"# DKA vs HHS + Acute Management + Drug Class Table\n## DKA vs HHS core\n- DKA: insulin deficiency + ketogenesis + anion-gap metabolic acidosis.\n- HHS: extreme hyperglycemia/hyperosmolarity 중심, 보통 ketosis는 경미.\n\n## Emergency sequence\n1. isotonic fluids로 intravascular volume 먼저 회복.\n2. potassium 상태를 먼저 확인/보정 후 insulin 진행.\n3. insulin infusion 중 anion gap closure를 치료 종료 기준으로 삼는다.\n4. glucose가 먼저 떨어져도 gap이 안 닫히면 dextrose 병행하며 insulin 지속.\n\n## Antidiabetic drug class table\n| 약물 계열 | 핵심 기전/장점 | 주요 주의점 |\n| --- | --- | --- |\n| Metformin | hepatic glucose output 감소, first-line | eGFR 저하/젖산산증 위험 상황 주의 |\n| Sulfonylurea | insulin secretion 증가 | hypoglycemia, weight gain |\n| TZD | insulin sensitivity 개선 | edema/heart failure 악화 가능 |\n| GLP-1 RA | 체중감소 + CV benefit | GI adverse effect, 특정 종양 병력 주의 |\n| DPP-4 inhibitor | incretin 효과 연장 | 상대적 효능/부작용 profile 고려 |\n| SGLT2 inhibitor | cardiorenal benefit, glycosuria | genital/urinary infection, euglycemic DKA 주의 |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-101","focus_area":"DKA HHS and Drug Classes","tags":["usmle-step2","endocrinology","dka","hhs","pharmacology","table"]}
{"chunk_type":"transcript_chunk","text":"# Insulin Strategy + T2DM Outpatient Escalation\n## Insulin use framework\n- basal-bolus 접근이 inpatient glycemic control의 표준.\n- correction insulin은 보조 수단이며 sliding scale 단독은 피한다.\n\n## Outpatient escalation\n- metformin 시작 후 A1c 미달 시 comorbidity-driven add-on 적용.\n- severe hyperglycemia/catabolic state에서는 초기 insulin 도입을 우선 고려.\n\n## Comorbidity-based add-on table\n| 동반 질환 | 우선 고려 약물 | 근거 포인트 |\n| --- | --- | --- |\n| Heart failure | SGLT2 inhibitor | HF hospitalization 감소 |\n| CKD | SGLT2 inhibitor(적응증 범위 내) | renal outcome 개선 |\n| ASCVD | GLP-1 RA 또는 SGLT2 inhibitor | major CV event 감소 |\n| Obesity | GLP-1 RA | weight loss 효과 |\n| 비용 제약 | sulfonylurea/TZD | 저비용 대안(부작용 trade-off) |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-121","focus_area":"Insulin and T2DM Escalation","tags":["usmle-step2","endocrinology","diabetes","insulin","treatment","table"]}
{"chunk_type":"transcript_chunk","text":"# Diabetic Nephropathy + Metabolic Syndrome + Hypoglycemia Intro\n## Diabetic nephropathy\n- hyperfiltration과 intraglomerular pressure 상승이 초기 손상 축.\n- UACR로 미세알부민뇨를 조기 발견하고, 당뇨 유형별 screening 시점을 지킨다.\n- microalbuminuria가 확인되면 혈압과 무관하게 ACEi/ARB를 신장보호 목적으로 고려.\n- SGLT2 inhibitors는 CKD progression 지연에 중요한 축.\n\n## Metabolic syndrome\n- central obesity, TG, HDL, BP, fasting glucose 요소를 조합해 CV risk를 구조적으로 평가.\n\n## Transition\n- 다음 단계는 저혈당 정의/응급처치/원인감별 알고리즘.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-141","focus_area":"Diabetic Nephropathy and Metabolic Syndrome","tags":["usmle-step2","endocrinology","nephropathy","metabolic-syndrome","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Hypoglycemia Workup + DKA Drug Pearls + Adrenal Entry\n## Hypoglycemia basics\n- Whipple triad로 true hypoglycemia 확인 후 즉시 처치.\n- awake면 oral rapid carbohydrate, unconscious면 IV dextrose 또는 IM glucagon.\n\n## Etiology differentiation table\n| Condition | Insulin | C-peptide | Pro-insulin | Sulfonylurea screen |\n| --- | --- | --- | --- | --- |\n| Exogenous insulin | High | Low | Low | Negative |\n| Insulinoma | High | High | High | Negative |\n| Sulfonylurea exposure | High | High | Variable/normal-high | Positive |\n\n## Rapid pearls\n- DKA/HHS는 fluids-first.\n- insulin 시작 전 potassium safety check 필수.\n- cardiorenal comorbidity에서는 SGLT2 기반 전략 고려.\n\n## Adrenal framework entry\n- adrenal mass 접근 원칙: functional 여부를 biochemical testing으로 먼저 확인.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-161","focus_area":"Hypoglycemia Workup and Adrenal Entry","tags":["usmle-step2","endocrinology","hypoglycemia","diagnosis","table","adrenal"]}
{"chunk_type":"transcript_chunk","text":"# Adrenal Pathology Core: Hyperaldosteronism, Cushing, Pheochromocytoma, Insufficiency\n## Primary hyperaldosteronism\n- resistant HTN + hypokalemia 의심.\n- screen(aldosterone/renin), confirmatory suppression test, subtype localization 순서.\n- unilateral lesion은 수술, bilateral hyperplasia는 MRA 치료.\n\n## Cushing syndrome\n- clinical phenotype 확인 후 적절한 screening test 조합으로 확진.\n- ACTH level로 ACTH-dependent 여부 분기하고 high-dose dex/영상으로 원인 분화.\n\n## Pheochromocytoma\n- paroxysmal headache/palpitation/sweating + episodic HTN.\n- metanephrine 기반 진단.\n- 수술 전 alpha blockade 후 beta blockade 순서(절대 역전 금지).\n\n## Adrenal insufficiency\n- primary vs secondary/tertiary를 전해질/ACTH/색소침착으로 구분.\n- adrenal crisis는 검사 대기 없이 stress-dose steroid + fluid resuscitation 즉시 시작.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-181","focus_area":"Adrenal Pathology Core","tags":["usmle-step2","endocrinology","adrenal","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"# Adrenal Rapid Recap + Thyroid/Adrenal Tumor Algorithm Entry\n## Rapid recap\n1. Conn syndrome: screen -> confirm -> subtype 분화 후 치료 결정.\n2. Cushing: 최소 2개 screening test 양성으로 확인.\n3. 전해질 패턴과 색소침착은 부신 질환 분류에 매우 유용.\n4. refractory hypotension은 adrenal crisis를 항상 포함해 평가.\n5. steroid exposure 병력은 secondary adrenal insufficiency를 우선 의심.\n\n## Transition\n- 이후 파트는 thyroid nodule/adrenal mass를 algorithm 기반으로 접근한다.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-199","focus_area":"Adrenal Recap and Tumor Algorithm Entry","tags":["usmle-step2","endocrinology","adrenal","recap","algorithm"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Nodule Algorithm + Pediatric Neck Mass + Thyroid Lymphoma/Storm\n## Thyroid nodule stepwise approach\n- **Step 1: TSH**로 hot vs cold 방향을 먼저 가른다.\n- low TSH면 hyperfunctioning nodule 평가(scintigraphy) 우선, 대개 malignancy risk 낮음.\n- normal/high TSH면 ultrasound risk feature를 본 뒤 필요 시 FNA.\n\n## Pediatric midline neck mass\n- thyroglossal duct cyst 의심 시 수술 전 정상 위치 갑상선 존재를 반드시 확인.\n- ectopic thyroid를 절제해 영구 hypothyroidism 만드는 실수를 피해야 함.\n\n## Thyroid emergencies/malignancy context\n- Hashimoto background에서 급격히 커지는 hard neck mass는 lymphoma 의심.\n- thyroid storm은 고열/빈맥/신경정신 증상 동반하는 응급으로 즉시 다중 약제 치료 필요.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-209","focus_area":"Thyroid Nodule and Pediatric Neck Mass","tags":["usmle-step2","endocrinology","thyroid","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# Thyroid Storm Differential + Adrenal Tumors + MEN Syndromes\n## Thyroid storm differential\n| 구분 | Thyroid storm | Malignant hyperthermia |\n| --- | --- | --- |\n| 공통점 | 수술/스트레스 이후 고열·빈맥 가능 | 수술/마취 이후 고열·빈맥 가능 |\n| 차이점 | 강한 교감항진 + thyroid toxicosis 맥락, 강직은 전형적이지 않음 | 전신 강직/마취약 연관이 두드러짐 |\n| 치료 핵심 | cooling + beta-blocker + thionamide + iodine + steroid | dantrolene 중심 |\n\n## Adrenal tumors\n- pheochromocytoma는 catecholamine surges로 episodic symptoms 유발.\n- neuroblastoma는 소아 복부 종괴에서 midline crossing/opsoclonus-myoclonus가 단서.\n- incidental adrenal mass는 biopsy 전 hormonal evaluation 우선.\n\n## MEN syndromes table\n| Syndrome | 핵심 구성 |\n| --- | --- |\n| MEN1 | Pituitary + Parathyroid + Pancreatic neuroendocrine tumors |\n| MEN2A | Medullary thyroid carcinoma + Pheochromocytoma + Parathyroid hyperplasia |\n| MEN2B | Medullary thyroid carcinoma + Pheochromocytoma + Mucosal neuroma/Marfanoid habitus |","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-229","focus_area":"Thyroid Storm Adrenal Tumors MEN","tags":["usmle-step2","endocrinology","thyroid-storm","pheochromocytoma","men","table"]}
{"chunk_type":"recap_summary","text":"# Endocrine Oncology Rapid Fire Recap\n- thyroid nodule은 TSH-first algorithm을 고정 원칙으로 적용.\n- low TSH hyperfunctioning lesion은 malignant risk가 낮아 접근이 다르다.\n- thyroglossal duct cyst는 ectopic thyroid 배제 후 수술.\n- pheochromocytoma는 metanephrine 진단 + alpha-before-beta 전처치.\n- MEN syndrome 패턴은 종양 조합으로 암기한다.\n- 갑상선폭풍/부신위기는 즉시 치료가 예후를 좌우한다.","subject":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","page_title":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","episode":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","section_path":["LM_endo 2 2f346f2986ee806b85b4c09245ef8c59"],"source_doc_id":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59","source_page":null,"source_anchor":"LM_endo 2 2f346f2986ee806b85b4c09245ef8c59-249","focus_area":"Endocrine Oncology Rapid Recap","tags":["usmle-step2","endocrinology","recap","oncology","next-step"]}
